Abstract
Continuous subcutaneous apomorphine infusion (CSAI) is increasingly used in Parkinson's disease (PD), notably in patients contraindicated for subthalamic deep brain stimulation. Although it has been suggested that CSAI is safe regarding cognition, few studies have actually investigated its effect, especially on cognitive control which is a crucial process for goal-directed behavior. More specifically, its impact on the dynamics of cognitive action control, as reflected by the activation and suppression of impulsive responses, has yet to be investigated, which is the objective of the present study. We compared cognitive action control between baseline (M0) and 6 months (M6) after the start of add-on CSAI by administering an oculomotor Simon task to 20 patients with mild to moderate PD. We used the activation-suppression model to determine whether CSAI had an effect on either the impulsive errors made in conflict situations or the suppression of these responses. We found no difference between M0 and M6 in the congruence effect regarding either reaction time or accuracy, indicating that overall conflict resolution was not influenced by CSAI. Furthermore, the rate of fast errors in the conflict situation and the last slope of the d...Continue Reading
References
Jul 1, 1969·Journal of Experimental Psychology·J R Simon
May 1, 1967·Neurology·M M Hoehn, M D Yahr
Aug 1, 1994·Journal of Neurology, Neurosurgery, and Psychiatry·E RůzickaR Jech
Sep 25, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Montse AlegretEduardo Tolosa
Mar 18, 2006·Journal of Neurology, Neurosurgery, and Psychiatry·D De GaspariA Antonini
Sep 2, 2008·Neuropsychologia·S A WylieG F Wooten
Aug 26, 2009·Journal of Cognitive Neuroscience·Scott A WylieWery P M van den Wildenberg
Sep 24, 2010·Brain : a Journal of Neurology·Scott A WylieWery P M van den Wildenberg
Dec 24, 2010·Frontiers in Human Neuroscience·Wery P M van den WildenbergK Richard Ridderinkhof
Sep 6, 2011·Parkinsonism & Related Disorders·Sophie DrapierMarc Vérin
May 9, 2012·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Samo Ribarič
May 11, 2012·Journal of Cognitive Neuroscience·Scott A WylieWery P M van den Wildenberg
Aug 25, 2012·Journal of Neurology, Neurosurgery, and Psychiatry·Scott A WylieCarol A Manning
Jan 1, 2011·Journal of Parkinson's Disease·Pablo Martinez-MartinKallol Ray Chaudhuri
Mar 1, 2011·Wiley Interdisciplinary Reviews. Cognitive Science·K Richard RidderinkhofWery P M van den Wildenberg
Feb 3, 2016·Journal of Cognitive Neuroscience·Nelleke C van WouweScott A Wylie
Apr 10, 2016·Journal of Neurology·Sophie DrapierDavid Devos
Nov 9, 2016·Frontiers in Aging Neuroscience·Joan DuprezPaul Sauleau
Dec 13, 2016·Parkinsonism & Related Disorders·Miguel Rosa-GriloK Ray Chaudhuri
Jan 1, 2017·Neuropsychologia·Joan DuprezPaul Sauleau
Oct 17, 2017·Parkinsonism & Related Disorders·Robbert W K Borgemeester, Teus van Laar